Patents for humanity: Special edition of Technology and Innovation

How universities and government are reaching the next billion people

2014-10-30

(Press-News.org) TAMPA, Fla. (Oct. 30, 2014) – The current special issue of Technology and Innovation, is devoted to patents that benefit people around the world who live with limited resources, in challenging environments, and are in need of better access to basic needs and improved standards of living, health and infrastructure.

The issue includes original articles from winners of the 2013 USPTO Patents for Humanity Awards, aimed at rewarding innovators for deploying patented technologies to address humanitarian needs. Winners featured in the issue include SIGN Fracture Care International, the University of California, Berkeley and Nokero International Ltd.

Other institutions represented include the University of South Florida (USF); University of Toronto; Institute for Regulatory Science; University of Tennessee Chattanooga, and Technopolis Group Austria on behalf of the European Patent Office.

In a lead-off editorial Edward Elliott, Attorney Advisor at the United States Patent and Trademark Office (USPTO), wrote, "The great challenge of the 21st century is in extending the benefits of modern technology to the less fortunate around the world." According to Elliott, universities, forces for socially conscious actions that benefit humanity, occupy a central role in the innovation system not only by developing new and beneficial technologies, but also by commercializing them through technology transfer.

Three Patents for Humanity winners detail their technologies in the issue. SIGN Fracture Care International's technology is a patented method for treating fractures without needing access to electricity. Researchers at the University of California, Berkeley engineered a yeast strain from the Artemisia plant in making a critical anti-malarial drug, their award-winning technology. Nokero's award-winning patented light bulb uses solar energy to provide light in areas of energy poverty.

"We are delighted to be showcasing the USPTO's Patents for Humanity competition in this issue," said Dr. Paul R. Sanberg, Editor-in-Chief of Technology and Innovation and AAAS-Lemelson Invention Ambassador. "The inventors featured here are making a real difference in the world."

In another article, Alfred Radauer of the Technopolis Group discusses the impact of a similar award, the European Inventor Award, given for inventions with high economic and societal impact in Europe. The paper, by Dean and Barbara Martin (USF), details how case studies of Kamlet Laboratories provide insight into technology development and patenting when government sources are limited.

Jaipreet Virdi-Dhesi provides a historical look at the nineteenth century technology invented by James Yearsley, an artificial tympanum for the ear, a hearing aid device made of cotton and thread, in her article. Authors from the Institute for Regulatory Science and George Mason University discuss the evolution of regulatory science from the development of metrics for evaluating regulatory science information, to peer review and risk assessment.

The final article, from the Erlanger Institute, discusses developing new pathways for clinical research in the "changing environment of the 21st century" and how increasingly high costs of clinical research and financial support for research have opened the door for industry-sponsored research.

Elliott's editorial also outlines the results of the Patents for Humanity awards. The program kicked-off in 2012 and attracted 81 applications. Universities contributed to a large number of applications, with about 10% from universities directly and another 67% from university-related categories (individuals and small companies, including university researchers and startups).

In April 2013, the program's inaugural awards were given to ten winners in five categories: Medicines and Vaccines; Medical Diagnostics and Devices; Food and Nutrition; Clean Technology; and Information Technology. Renewed in 2014 by the White House, the annual Patents for Humanity awards competition is underway with five new categories: Medicine; Nutrition; Sanitation; Household Energy; and Living Standards.

"For more than two hundred years, patents have provided the engine for technological and economic progress in industrialized nations, with universities supplying much of the fuel through basic research," concluded Elliott in his editorial. "As we strive to bring the benefits of modern technology to the next billion of humanity, patents continue to play an essential role in creating lasting solutions."

INFORMATION: Full-text articles of the latest issue of Technology and Innovation: http://ingentaconnect.com/content/cog/ti

The National Academy of Inventors is a 501(c)(3) non-profit member organization comprising U.S. and international universities, and governmental and non-profit research institutes, with over 3,000 individual inventor members and Fellows spanning more than 200 institutions, and growing rapidly. It was founded in 2010 to recognize and encourage inventors with patents issued from the U.S. Patent and Trademark Office, enhance the visibility of academic technology and innovation, encourage the disclosure of intellectual property, educate and mentor innovative students, and translate the inventions of its members to benefit society. The NAI offices are located in the USF Research Park in Tampa. The NAI edits the multidisciplinary journal, Technology and Innovation, published by Cognizant Communication Corporation (NY). http://www.academyofinventors.org

The editorial offices of Technology and Innovation are located in the USF Research Park, 3702 Spectrum Blvd., Suite 165, Tampa, Florida, 33612 USA. Tel: +1-813-974-1347. Email TIJournal@research.usf.edu

[Attachments] See images for this press release:

Patents for humanity: Special edition of Technology and Innovation 2

ELSE PRESS RELEASES FROM THIS DATE:

Lou Gehrig's disease study: Renewing brain's aging support cells may help neurons survive

2014-10-30

LOS ANGELES (Oct. 29, 2014) – Lou Gehrig's disease, also known as amyotrophic lateral sclerosis, or ALS, attacks muscle-controlling nerve cells – motor neurons – in the brain, brainstem and spinal cord, leading to progressive weakness and eventual paralysis of muscles throughout the body. Patients typically survive only three to five years after diagnosis. Now, with publication of a study by investigators at the Cedars-Sinai Board of Governors Regenerative Medicine Institute, ALS researchers know the effects of the attack are worsened, at least in part, ...

Smithsonian scientist discovers populations of rare songbird in surprising new habitat

2014-10-30

The Swainson's warbler (Limnothlypis swainsonii) is one of the rarest and most secretive songbirds in North America, prized by birdwatchers in the southeastern U.S. hoping to catch a glimpse of it in the wild or hear its beautiful ringing song. With only 90,000 breeding individuals sparsely distributed across 15 states in the U.S., the Swainson's warbler is a species of high conservation concern that, for decades, has left conservationists with little confidence that its populations would ever be fully secure. However, new research published in the Oct. 30 edition of ...

National initiative shows multisystem approaches to reduce diabetes disparities

2014-10-30

Washington, DC – Exciting results from an innovative, multicultural, five-year initiative, known as the Alliance to Reduce Disparities in Diabetes (Alliance), have been published in ten peer-reviewed articles in the November 2014 supplemental issue of Health Promotion Practice (HPP). The findings reveal that a new model of chronic disease management for vulnerable populations with diabetes shows significant promise in strengthening coordination of care, reducing diabetes health disparities and improving health outcomes. Funded by Merck Foundation, the Alliance ...

Model by NIH grantees explains why HIV prevention dosing differs by sex

2014-10-30

WHAT: A mathematical model developed by NIH grantees predicts that women must take the antiretroviral medication Truvada daily to prevent HIV infection via vaginal sex, whereas just two doses per week can protect men from HIV infection via anal sex. This finding helps explain why two large clinical trials testing HIV pre-exposure prophylaxis, or PrEP, in women failed to show efficacy. Participants in the VOICE and FEM-PrEP trials of Truvada and tenofovir (another antiretroviral) for HIV prevention were counseled to take one of the medications daily. However, because they ...

Seeing dinosaur feathers in a new light

2014-10-30

Why were dinosaurs covered in a cloak of feathers long before the early bird species Archaeopteryx first attempted flight? Researchers from the University of Bonn and the University of Göttingen attempt to answer precisely that question in their article "Beyond the Rainbow" in the latest issue of the renowned journal Science. The research team postulates that these ancient lizards had a highly developed ability to discern color. Their hypothesis: The evolution of feathers made dinosaurs more colorful, which in turn had a profoundly positive impact on communication, ...

The geometry of RNA

2014-10-30

Messenger, transfer, ribosomal... there's more than one type of RNA. The difference lies not only in the sequence of the nucleotides, the "beads" that form the strand, but also in the three-dimensional structure that this long molecule takes on. Computer models are often used to reveal this structure but these tend to be rather complex, and they vary depending on the field of application. A team of SISSA scientists used numerical techniques to develop a new "geometrical" model which has the advantage of being much simpler and faster than those traditionally used as well ...

Cochrane Review of RDT for diagnosis of drug resistant TB

2014-10-30

Researchers from the Cochrane Infectious Diseases Group, hosted at LSTM, have conducted an independent review to examine the diagnostic accuracy of the GenoType® MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs. While there are a number of different drugs available to people suffering from tuberculosis (TB), resistance to these drugs is a growing problem. People suffering from a drug-resistant strain of TB are more likely to die from the disease, and require treatment with what are described as "second-line" drugs. These drugs can ...

New tech aims to improve communication between dogs and humans

2014-10-30

North Carolina State University researchers have developed a suite of technologies that can be used to enhance communication between dogs and humans, which has applications in everything from search and rescue to service dogs to training our pets. "We've developed a platform for computer-mediated communication between humans and dogs that opens the door to new avenues for interpreting dogs' behavioral signals and sending them clear and unambiguous cues in return," says Dr. David Roberts, an assistant professor of computer science at NC State and co-lead author of a paper ...

Ion adsorption matter in biology

2014-10-30

New York | Heidelberg, 30 October 2014 Biological membranes are mainly composed of lipid bilayers. Gaining a better understanding of adsorption of solution ions onto lipid membranes helps clarify functional processes in biological cells. Now, a new study provides a quantitative description of the equilibria between lipid membranes and surrounding solution ions. Joanna Kotyńska and Zbigniew Figaszewski from the University of Bialystok, Poland, are the authors of a study describing these findings, just published in EPJ E. In addition to shedding some light on biological ...

Accident prone eczema patients

2014-10-30

CHICAGO --- Intense itching and dry, irritable skin aren't the only problems adults with eczema face. They are at greater risk of accidental bone fractures and other injuries, a new Northwestern Medicine® study has found. This is the first study to find adult eczema is a risk factor for fractures and other injuries. The increased odds of accidental injury could be directly related to the side effects of steroids and sedating antihistamines commonly prescribed to treat the skin disorder or the under-treatment of severe cases, study authors suggest. "Many eczema ...

Patents for humanity: Special edition of Technology and Innovation

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: